Presenilin 1 mediates retinoic acid‐induced differentiation of SH‐SY5Y cells through facilitation of Wnt signaling

Presenilin 1 interacts with β‐catenin, an essential component of the Wnt signaling pathway. To elucidate the role of presenilin 1‐β‐catenin interaction in neuronal differentiation, we established SH‐SY5Y cells stably expressing wild‐type presenilin 1, P117L mutant presenilin 1, which is linked to the early‐onset familial form of Alzheimer's disease, and D385A mutant presenilin 1, which has no aspartyl proteinase activity. We demonstrate that SH‐SY5Y cells stably expressing D385A mutant presenilin 1 failed to differentiate in response to retinoic acid treatment. Retinoic acid caused an increase in nuclear β‐catenin levels in SH‐SY5Y cells, which was followed by an increase in cyclin D1 protein levels. Abnormal cellular accumulation of β‐catenin was observed in D385A mutant transfected cells, whereas nuclear β‐catenin and cellular cyclin D1 levels failed to increase. Conversely, SH‐SY5Y cells expressing the P117L mutant differentiated normally and showed increased nuclear β‐catenin and cellular cyclin D1 levels. These findings suggest that neuronal differentiation of SH‐SY5Y cells involves the Wnt signaling pathway and that presenilin 1 plays a crucial role in Wnt signal transduction by regulating the nuclear translocation of β‐catenin. © 2003 Wiley‐Liss, Inc.

[1]  Raphael Kopan Faculty Opinions recommendation of Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. , 2003 .

[2]  Hui Zheng,et al.  The aspartate-257 of presenilin 1 is indispensable for mouse development and production of β-amyloid peptides through β-catenin-independent mechanisms , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Levey,et al.  Presenilin 1 Independently Regulates β-Catenin Stability and Transcriptional Activity* , 2001, The Journal of Biological Chemistry.

[4]  Hui Zheng,et al.  Loss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Iavarone,et al.  Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Shibamoto,et al.  Inhibitory effect of a presenilin 1 mutation on the Wnt signalling pathway by enhancement of beta-catenin phosphorylation. , 2001, European journal of biochemistry.

[7]  K. Herrup,et al.  DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease , 2001, The Journal of Neuroscience.

[8]  Hui Zheng,et al.  Presenilin 1 Negatively Regulates β-Catenin/T Cell Factor/Lymphoid Enhancer Factor-1 Signaling Independently of β-Amyloid Precursor Protein and Notch Processing , 2001, The Journal of cell biology.

[9]  R. Tanzi,et al.  GSK3β Forms a Tetrameric Complex with Endogenous PS1‐CTF/NTF and β‐Catenin: Effects of the D257/D385A and FAD‐linked Mutations , 2000 .

[10]  S. Janicki,et al.  Familial Alzheimer’s disease presenilin-1 mutants potentiate cell cycle arrest , 2000, Neurobiology of Aging.

[11]  T. Arendt Alzheimer’s disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain , 2000, Neurobiology of Aging.

[12]  Min Xu,et al.  Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.

[13]  B. Strooper Alzheimer's disease: Closing in on γ-secretase , 2000, Nature.

[14]  A. Bauer,et al.  Apoptosis-induced Cleavage of β-Catenin by Caspase-3 Results in Proteolytic Fragments with Reduced Transactivation Potential* , 2000, The Journal of Biological Chemistry.

[15]  D. Selkoe,et al.  The Transmembrane Aspartates in Presenilin 1 and 2 Are Obligatory for γ-Secretase Activity and Amyloid β-Protein Generation* , 2000, The Journal of Biological Chemistry.

[16]  F. Nicoletti,et al.  Mitotic signaling by β‐amyloid causes neuronal death , 1999 .

[17]  K. Tieu,et al.  Differential effects of staurosporine and retinoic acid on the vulnerability of the SH‐SY5Y neuroblastoma cells: Involvement of Bcl‐2 and p53 proteins , 1999, Journal of neuroscience research.

[18]  B. de Strooper,et al.  Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons , 1999, The Journal of cell biology.

[19]  S. Janicki,et al.  Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant. , 1999, The American journal of pathology.

[20]  V. C. Yu,et al.  Retinoic Acid Confers Resistance to p53-dependent Apoptosis in SH-SY5Y Neuroblastoma Cells by Modulating Nuclear Import of p53* , 1999, The Journal of Biological Chemistry.

[21]  M. Frosch,et al.  Presenilin 1 Facilitates the Constitutive Turnover of β-Catenin: Differential Activity of Alzheimer’s Disease–Linked PS1 Mutants in the β-Catenin–Signaling Pathway , 1999, The Journal of Neuroscience.

[22]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Kitagawa,et al.  An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin , 1999, The EMBO journal.

[24]  A. Iavarone,et al.  Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. , 1999, Blood.

[25]  Richard J. Lee,et al.  pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. , 1999, The Journal of biological chemistry.

[26]  R. Rozmahel,et al.  Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin,a component of the presenilin protein complex , 1999, Nature Medicine.

[27]  D. Bredesen,et al.  Contrasting Role of Presenilin-1 and Presenilin-2 in Neuronal Differentiation In Vitro , 1999, Journal of Neuroscience.

[28]  R. Tanzi,et al.  Abrogation of the Presenilin 1/β-Catenin Interaction and Preservation of the Heterodimeric Presenilin 1 Complex following Caspase Activation* , 1998, The Journal of Biological Chemistry.

[29]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[30]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[31]  A. Takashima,et al.  Direct association of presenilin‐1 with β‐catenin , 1998 .

[32]  Richard J. Lee,et al.  Transforming Potential of Dbl Family Proteins Correlates with Transcription from the Cyclin D1 Promoter but Not with Activation of Jun NH2-terminal Kinase, p38/Mpk2, Serum Response Factor, or c-Jun* , 1998, The Journal of Biological Chemistry.

[33]  P. Fraser,et al.  The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-Catenin* , 1998, The Journal of Biological Chemistry.

[34]  K. Herrup,et al.  Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain , 1998, The Journal of Neuroscience.

[35]  J. Buxbaum,et al.  A novel Polish presenilin‐1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years , 1998, Neuroreport.

[36]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[37]  C. L. Harris,et al.  Evidence That Levels of Presenilins (PS1 and PS2) Are Coordinately Regulated by Competition for Limiting Cellular Factors* , 1997, The Journal of Biological Chemistry.

[38]  E. Ziff,et al.  Nerve Growth Factor Induces Transcription of the p21 WAF1/CIP1 and Cyclin D1 Genes in PC12 Cells by Activating the Sp1 Transcription Factor , 1997, The Journal of Neuroscience.

[39]  M. Staufenbiel,et al.  Developmental Regulation of Presenilin-1 Processing in the Brain Suggests a Role in Neuronal Differentiation* , 1997, The Journal of Biological Chemistry.

[40]  G. Jicha,et al.  Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.

[41]  C. Haass Presenilins: Genes for Life and Death , 1997, Neuron.

[42]  C. Der,et al.  Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways , 1997, Molecular and cellular biology.

[43]  U. Gärtner,et al.  Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.

[44]  J. Trojanowski,et al.  Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[46]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[47]  C. Albanese,et al.  Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[48]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[49]  C. Albanese,et al.  Epidermal Growth Factor and c-Jun Act via a Common DNA Regulatory Element to Stimulate Transcription of the Ovine P-450 Cholesterol Side Chain Cleavage (CYP11A1) Promoter (*) , 1995, The Journal of Biological Chemistry.

[50]  S. Ng,et al.  Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells , 1995, Molecular and cellular biology.

[51]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[52]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.

[53]  V. Giguère,et al.  Identification of a receptor for the morphogen retinoic acid , 1987, Nature.

[54]  A. Nordberg,et al.  Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. , 1987, Brain research.

[55]  D L Price,et al.  Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.

[56]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[57]  Hui Zheng,et al.  The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  D. Selkoe,et al.  The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. , 2000, The Journal of biological chemistry.

[59]  R. Tanzi,et al.  GSK3 beta forms a tetrameric complex with endogenous PS1-CTF/NTF and beta-catenin. Effects of the D257/D385A and FAD-linked mutations. , 2000, Annals of the New York Academy of Sciences.

[60]  B. de Strooper Alzheimer's disease. Closing in on gamma-secretase. , 2000, Nature.

[61]  A. Nadin,et al.  Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. , 2000, Nature.

[62]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[63]  F. Nicoletti,et al.  Mitotic signaling by beta-amyloid causes neuronal death. , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  A. Takashima,et al.  Direct association of presenilin-1 with beta-catenin. , 1998, FEBS letters.

[65]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.